Home

Kathleen D. Scott

CIK 1794284 · Chief Financial Officer · last filed 2026-06-16

Kathleen D. Scott is a Chief Financial Officer who has filed 26 SEC Form 4 insider transactions across 4 companies since 2019. The most recent filing shows the insider sold $13 of DRMAW on Jun 16, 2026. Across all open-market trades the lifetime net is −$1.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $103.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$103.7K

Companies

4

Total Filings

26

Lifetime Open-Market Net

-$1.24M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DRMAW Director 1 $0.01 $0 -$13 9 2026-06-16
SPRY Chief Financial Officer 18,292 $5.67 $103.7K -$1.24M 10 2026-01-05
NKGen Biotech, Inc. (NKGNW) Delisted Director — $0.03 — $0 2 2024-12-10
Histogen Inc. (CNAT) Delisted Director — — — $0 1 2019-11-19

Recent Filings

26 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-16 DRMAW Sell (S) −11 -$13 EDGAR
2026-01-06 DRMAW Grant (A) — $0 EDGAR
2026-01-05 SPRY Grant (A) — $0 EDGAR
2025-08-22 SPRY Mixed — -$168.8K EDGAR
2025-08-21 SPRY Notice (144) −12,500 -$187.5K EDGAR
2025-05-22 SPRY Mixed — -$630.2K EDGAR
2025-05-20 SPRY Notice (144) −50,000 -$705.0K EDGAR
2025-01-14 DRMAW Grant (A) — $0 EDGAR
2025-01-03 SPRY Grant (A) — $0 EDGAR
2024-12-10 NKGen Biotech, Inc. (NKGNW) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 26
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.